Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 00:52:53 - browse：9684

Adam's take main illustration — Molly Ferguson/STAT

Annovis Bio had my biotech bull%^&! meter running red after it made a late change to the design of a Phase 3 study in Parkinson’s disease. But then I got an extraordinary explanation from CEO Maria Maccecchini. Now, I’m less worried about data spin because, by her own admission, the odds that the study succeeds, post endpoint change, are a lot lower.

Results from the completed Parkinson’s study, which is investigating Annovis’ drug called buntanetap, are well past due because of what the company has described as ongoing “data cleaning efforts.” The delay was announced on Jan. 24. Two weeks later, on Feb. 6, the primary efficacy endpoint of the study was changed, according to an update posted to the U.S. government’s clinical trials database.

Red flag, I thought, until I emailed Maccecchini, asking for an explanation. In response, she told me Annovis made the key endpoint change in August, based on a recommendation from officials at the Food and Drug Administration after the agency had reviewed data from an interim analysis of the study. It took the company another six months to update the study design in the ClinicalTrials.gov database, for reasons she did not explain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

hotspot

focus

WSS

Flagship Pioneering launches a new biotech in two countries

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Russians and Belarusians back at Wimbledon as war in Ukraine continues

BIO selects John Crowley as new CEO

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

4 dead, 2 in stable condition in Philadelphia shooting: Police

focus

Wikipedia

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

US judge blocks portions of new Florida elections law

How one medical school became remarkably diverse

The EPA's new lead rule: How one expert crunched the numbers

Guidelines to prevent youth baseball injuries need more muscle

Takeda, Janssen join wearable maker to measure scratching

State Dept. review finds Biden bears some blame for Afghanistan failures

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Heart attack and stroke risk calculators need revising

FDA investigates CAR

knowledge

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

The EPA's new lead rule: How one expert crunched the numbers

1 dead, 9 hurt in July 4th fireworks explosion

CDC director unscathed in first congressional testimony

What don’t we know about an Alzheimer’s drug side effect?

knowledge

hotspot

focus

entertainment